<DOC>
	<DOCNO>NCT01755897</DOCNO>
	<brief_summary>We conduct trial determine whether paclitaxel/cisplatin ( TP ) adjuvant chemotherapy radical surgery improve disease-free survival ( DFS ) overall survival ( OS ) , well quality life ( QoL ) among early-stage ( FIGO stage IB-IIA ) cervical cancer patient risk factor .</brief_summary>
	<brief_title>A Multicenter , Prospective , Randomized Trial Adjuvant Chemotherapy Early-Stage Cervical Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>FIGO stage : ⅠB～ⅡA , cervical cancer ; Age≤60 year ; female , Chinese woman ; Initial treatment radical hysterectomy + pelvic lymph node dissection ; Pathological diagnosis : cervical squamous cell invasive carcinoma ; Pathologic examination meet follow one indication adjuvant therapy : ① lymph node metastasis , ② parametrial invasion , ③ ≥ 2/3 deep stromal invasion , ④ histopathological grade poorly differentiate ( G2 G3 ) , ⑤ lymphatic vascular space involvement , ⑥ tumor diameter &gt; 4cm ; Laboratory test : WBC≥4×10 ( 9 ) /L , NEU≥2×10 ( 9 ) /L , PLT≥80×10 ( 9 ) /L , serum bilirubin≤ 1.5 time upper limit normal , transaminase≤ 1.5 time upper limit normal , BUN , Cr≤ normal Performance status : Karnofsky score≥60 ; No prior treatment ; Receiving extensive resection uterus ( type III ) plus pelvic lymph node wide resection ; pathologically diagnose cervical squamous cell carcinoma ; Provide write informed consent . With severe uncontrolled internal disease , unable receive surgery and/or unsuitable radiotherapy chemotherapy History organ transplantation , immune disease ; History serious mental illness , history brain dysfunction ; Drug abuse history drug abuse ; Suffering malignancy ; Concurrently participate clinical trial Unable unwilling sign informed consent ; Unable unwilling abide protocol .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>